1. Home
  2. BLLN vs LSTR Comparison

BLLN vs LSTR Comparison

Compare BLLN & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$131.26

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Landstar System Inc.

LSTR

Landstar System Inc.

HOLD

Current Price

$213.44

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
LSTR
Founded
2016
1988
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
7.0B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BLLN
LSTR
Price
$131.26
$213.44
Analyst Decision
Buy
Hold
Analyst Count
7
12
Target Price
$126.71
$173.83
AVG Volume (30 Days)
706.5K
404.5K
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
1.95%
EPS Growth
N/A
N/A
EPS
N/A
1.16
Revenue
N/A
$4,743,760,000.00
Revenue This Year
$46.29
$6.89
Revenue Next Year
$30.14
$9.05
P/E Ratio
N/A
$182.04
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$119.40
52 Week High
$138.70
$228.46

Technical Indicators

Market Signals
Indicator
BLLN
LSTR
Relative Strength Index (RSI) 64.33 57.43
Support Level $79.07 $202.41
Resistance Level $138.70 $214.80
Average True Range (ATR) 6.98 5.44
MACD -0.18 0.06
Stochastic Oscillator 94.63 75.87

Price Performance

Historical Comparison
BLLN
LSTR

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

Share on Social Networks: